循环微生物cfDNA片段末端作为脓毒症病原体检测特征
该研究对脓毒症患者血浆微生物cfDNA片段进行末端基序分析,发现微生物cfDNA末端基序谱与核cfDNA相似(Spearman相关系数0.82,P值0.001),CC末端基序最常见。感染病原体来源的微生物cfDNA富集CC末端,而试剂或环境污染微生物DNA末端近乎随机。片段末端特征鉴别确认病原体与污染微生物的AUC达0.99,优于仅基于丰度的传统分析。
要点
- 微生物cfDNA末端基序谱与核cfDNA相似,CC末端基序最常见,提示DNASE1L3可能参与其片段化。
- 感染病原体来源微生物cfDNA富集CC末端,污染微生物DNA末端近乎随机。
- 片段末端特征鉴别确认病原体与污染微生物的AUC为0.99,优于仅基于丰度的分析。
核心结论
- 片段组学特征有助于区分脓毒症中真正的病原体与潜在污染微生物,展示微生物cfDNA片段组学在宏基因组分析中的潜在用途。
研究设计与样本
- 对脓毒症患者血浆样本中的微生物cfDNA片段进行末端基序分析,采用基于序列背景的归一化方法减少末端基序分析的潜在偏倚。
主要发现
- 微生物cfDNA末端基序谱与核cfDNA相似,Spearman相关系数为0.82,P值0.001。
- CC末端基序是微生物cfDNA中最偏好的末端基序。
- 感染病原体来源的微生物cfDNA富集CC末端,污染微生物DNA末端近乎随机。
- 片段末端特征鉴别确认病原体与污染微生物的AUC为0.99,性能优于仅基于微生物cfDNA丰度的传统分析。
关键数值与推荐
- 微生物cfDNA末端基序谱与核cfDNA的Spearman相关系数为0.82,P值0.001。
- 片段末端特征鉴别确认病原体与污染微生物的AUC为0.99。
临床怎么用
- 在脓毒症宏基因组分析中,可考虑使用微生物cfDNA片段末端特征辅助区分真正病原体与污染微生物。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Nuclear-derived cell-free DNA (cfDNA) molecules in blood plasma are nonrandomly fragmented, bearing a wealth of information related to tissues of origin. DNASE1L3 (deoxyribonuclease 1 like 3) is an important player in shaping the fragmentation of nuclear-derived cfDNA molecules, preferentially generating molecules with 5 CC dinucleotide termini (i.e., 5 CC-end motif). However, the fragment end properties of microbial cfDNA and its clinical implication remain to be explored. METHODS: We performed end motif analysis on microbial cfDNA fragments in plasma samples from patients with sepsis. A sequence context-based normalization method was used to minimize the potential biases for end motif analysis. RESULTS: The end motif profiles of microbial cfDNA appeared to resemble that of nuclear cfDNA (Spearman correlation coefficient: 0.82, P value 0.001). The CC-end motif was the most preferred end motif in microbial cfDNA, suggesting that DNASE1L3 might also play a role in the fragmentation of microbe-derived cfDNA in plasma. Of note, differential end motifs were present between microbial cfDNA originating from infection-causing pathogens (enriched at the CC-end) and contaminating microbial DNA potentially derived from reagents or the environment (nearly random). The use of fragment end signatures allowed differentiation between confirmed pathogens and contaminating microbes, with an area under the receiver operating characteristic curve of 0.99. The performance appeared to be superior to conventional analysis based on microbial cfDNA abundance alone. CONCLUSIONS: The use of fragmentomic features could facilitate the differentiation of underlying contaminating microbes from true pathogens in sepsis. This work demonstrates the potential usefulness of microbial cfDNA fragmentomics in metagenomics analysis.
引用
- Wang G, Lam WKJ, Ling L, et al. Fragment Ends of Circulating Microbial DNA as Signatures for Pathogen Detection in Sepsis. Clin Chem. 2023. PMID: 36576350. doi:10.1093/clinchem/hvac197
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。